UTAH MEDICAL PRODUCTS INC
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $14.5M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $3.3M | 22.7% |
| Other Investing | $9.0K | 0.1% |
| Dividends Paid | $3.9M | 27.0% |
| Other Financing | $2.4M | 16.7% |
| Other | $1.9M | 12.9% |
| Net Cash Flow | $3.0M | 20.8% |